Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer

BACKGROUND: Inflammatory breast cancer (IBC) is a highly angiogenic disease; thus, antiangiogenic therapy should result in a clinical response. However, clinical trials have demonstrated only modest responses, and the reasons for these outcomes remain unknown. Therefore, the purpose of this retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Arias-Pulido, Hugo, Chaher, Nabila, Gong, Yun, Qualls, Clifford, Vargas, Jake, Royce, Melanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474178/
https://www.ncbi.nlm.nih.gov/pubmed/22813402
http://dx.doi.org/10.1186/1471-2407-12-298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474178/
https://www.ncbi.nlm.nih.gov/pubmed/22813402
http://dx.doi.org/10.1186/1471-2407-12-298

Ejemplares similares